18,031 results on '"Nanomedicine '
Search Results
2. Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo
3. Extracellular vesicles as vehicles for drug delivery to the heart
4. Exercise Inhibits Doxorubicin-Induced Cardiotoxicity via Regulating B Cells
5. Reduced uterine perfusion pressure as a model for preeclampsia and fetal growth restriction in murine: a systematic review and meta-analysis
6. Cardiac delivery of modified mRNA using lipid nanoparticles: Cellular targets and biodistribution after intramyocardial administration
7. A magnetic separation method for isolating and characterizing the biomolecular corona of lipid nanoparticles
8. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
9. Assessment of feto-placental oxygenation and perfusion in a rat model of placental insufficiency using T2* mapping and 3D dynamic contrast-enhanced MRI
10. Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells
11. Biofluid specific protein coronas affect lipid nanoparticle behavior in vitro
12. Lipid nanoparticles for nucleic acid delivery beyond the liver
13. Expanding lipid nanoparticle platforms for effective mRNA therapeutics
14. Inhibition of Hmbox1 Promotes Cardiomyocyte Survival and Glucose Metabolism Through Gck Activation in Ischemia/Reperfusion Injury
15. Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1
16. Extracellular vesicle-mediated delivery of CRISPR/Cas9 ribonucleoprotein complex targeting proprotein convertase subtilisin-kexin type 9 (Pcsk9) in primary mouse hepatocytes
17. Vitamin C facilitates direct cardiac reprogramming by inhibiting reactive oxygen species
18. mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond
19. Extracellular vesicle-mediated protein delivery to the liver
20. Fusogenic Coiled-Coil Peptides Enhance Lipid Nanoparticle-Mediated mRNA Delivery upon Intramyocardial Administration
21. Circular RNAs in Cardiovascular Diseases: Regulation and Therapeutic Applications
22. Cellular polyploidy in organ homeostasis and regeneration
23. Nanomedicines: An approach to treat placental insufficiency and the current challenges
24. Levodopa-loaded nanoparticles for the treatment of Parkinson's disease
25. Increased Bone Marrow Uptake and Accumulation of Very-Late Antigen-4 Targeted Lipid Nanoparticles
26. Insights in the Prothrombotic Changes after Implantation of a Left Ventricular Assist Device in Patients with End-Stage Heart Failure: A Longitudinal Observational Study
27. In-vitro and in-silico evidence for oxidative stress as drivers for RDW
28. TOP-EVs: Technology of Protein delivery through Extracellular Vesicles is a versatile platform for intracellular protein delivery
29. Factor XII Explored with AlphaFold - Opportunities for Selective Drug Development
30. EV-Elute: a universal platform for enrichment of functional surface marker-defined extracellular vesicle subpopulations
31. Risk Factors for Immune Checkpoint Inhibitor-Mediated Cardiovascular Toxicities
32. A New Open Access Journal: Molecular Biology & Nanomedicine
33. Evaluation and manipulation of tissue and cellular distribution of cardiac progenitor cell-derived extracellular vesicles
34. Small molecule-mediated rapid maturation of human induced pluripotent stem cell-derived cardiomyocytes
35. Inhibition of HIPK2 protects stress-induced pathological cardiac remodeling
36. VWF-targeted thrombolysis to overcome rh-tPA resistance in experimental murine ischemic stroke models
37. Extracellular vesicles enclosed-miR-421 suppresses air pollution (PM 2.5 )-induced cardiac dysfunction via ACE2 signalling.
38. Utilizing in vitro drug release assays to predict in vivo drug retention in micelles
39. VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow
40. Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles
41. Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement
42. Microlyse; a thrombolytic agent that targets VWF for clearance of microvascular thrombosis
43. Functional siRNA Delivery by Extracellular Vesicle–Liposome Hybrid Nanoparticles
44. A reactive center loop-based prediction platform to enhance the design of therapeutic SERPINs
45. Roadmap Consensus on Carotid Artery Plaque Imaging and Impact on Therapy Strategies and Guidelines: An International, Multispecialty, Expert Review and Position Statement
46. Esterase-Sensitive Prodrugs of a Potent Bisubstrate Inhibitor of Nicotinamide N-Methyltransferase (NNMT) Display Cellular Activity
47. Targeting of promising transmembrane proteins for diagnosis and treatment of pancreatic ductal adenocarcinoma
48. Modular Lipid Nanoparticle Platform Technology for siRNA and Lipophilic Prodrug Delivery
49. Crucial Role of miR-433 in Regulating Cardiac Fibrosis: Erratum
50. Profiling of Extracellular Small RNAs Highlights a Strong Bias towards Non-Vesicular Secretion
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.